Is Baxter a good stock to buy?
Is Baxter a good stock to buy?
We believe that Baxter stock is a good buying opportunity at the present time. BAX stock trades near $81 currently and it is, in fact, down 13% from its pre-Covid high of $93 in February 2020 – just before the coronavirus pandemic hit the world.
Is Baxter a public company?
Baxter International Inc. is an American multinational health care company with headquarters in Deerfield, Illinois….Baxter International.
| Type | Public |
|---|---|
| Traded as | NYSE: BAX S&P 500 component |
| Industry | Medical equipment |
| Founded | 1931 |
| Founder | Donald Baxter |
Is Baxter Healthcare part of Baxter International?
The company is a wholly owned subsidiary of Baxter International Inc., a United States-based pharmaceutical company.
Is BAX a buy or sell?
Baxter International has received a consensus rating of Buy. The company’s average rating score is 2.71, and is based on 11 buy ratings, 2 hold ratings, and 1 sell rating.
Who is buying HILL ROM?
Baxter International Inc.
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).
What type of company is Baxter Healthcare?
Baxter Healthcare Corporation operates as a healthcare company. The Company specializes in medical devices, pharmaceuticals and biotechnology.
Is BAX good stock?
The financial health and growth prospects of BAX, demonstrate its potential to outperform the market. It currently has a Growth Score of B. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
Is Baxter buying Hillrom?
Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today it has completed its acquisition of Hillrom. Baxter paid $156.00 in cash for each outstanding share of Hillrom common stock for a purchase price of $10.5 billion (based on Hillrom share counts at closing).
Why is Baxter buying Hillrom?
Baxter on Monday announced the completion of its $10.5 billion acquisition of Hillrom, a deal meant to expand the company’s digital health and connected care offerings.
